PTC Therapeutics Inc (PTCT)
45.35
-0.21
(-0.46%)
USD |
NASDAQ |
Dec 24, 16:00
PTC Therapeutics Cash from Investing (Quarterly): -42.68M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | -348.00M |
| ClearPoint Neuro Inc | -0.012M |
| Pfizer Inc | -2.057B |
| Blueprint Medicines Corp | 29.95M |
| BridgeBio Pharma Inc | 38.23M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -76.99M |
| Cash from Financing (Quarterly) | -17.63M |
| Free Cash Flow | -274.19M |
| Free Cash Flow Per Share (Quarterly) | -1.141 |
| Free Cash Flow to Equity (Quarterly) | -88.07M |
| Free Cash Flow to Firm (Quarterly) | -42.48M |
| Free Cash Flow Yield | -7.91% |